RiboNova
PrivateLast Round
Grant
Dec 12, 2019
Total Funding Raised
$524,431
Company Overview
RiboNova operates in Healthcare & Life Sciences and is based in Wynnewood, Oklahoma. Its latest recorded funding round was a Grant round in December 2019.
RiboNova is a biopharmaceutical company that develops small molecule drugs designed to treat serious rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboNova Comparables
Compare RiboNova with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 88% | |
| Base4 Biotechnology | 86% | |
| Expansion Therapeutics | 86% |
For institutional investors. Book with your work email.
RiboNova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2019 | ||||
| Grant | Dec 12, 2019 | ||||
| Seed | Jun 11, 2015 |
For institutional investors. Book with your work email.
RiboNova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioAdvance Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2019
$150K grant awarded by NIH RADx
For institutional investors. Book with your work email.
RiboNova Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RiboNova's valuation, stock price, and market status.
Is RiboNova a public or private company?
RiboNova is a private company.
What is the current stock price of RiboNova?
RiboNova is a private company, so its shares have no public market price. Caplight tracks RiboNova's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RiboNova worth (valuation)?
Valuation information for RiboNova is not publicly available.
Can I buy RiboNova stock?
RiboNova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RiboNova's last funding round?
RiboNova's most recent funding round was Grant on December 12, 2019.
Who are the main investors in RiboNova?
Key investors in RiboNova include NIH RADx, BioAdvance Capital.
Will RiboNova IPO soon?
No public IPO plans have been announced for RiboNova.
How can I track RiboNova secondary market activity?
Caplight tracks bids, offers, and trades in RiboNova's shares on secondary markets.